ID

34541

Beschreibung

A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics; ODM derived from: https://clinicaltrials.gov/show/NCT02470481

Link

https://clinicaltrials.gov/show/NCT02470481

Stichworte

  1. 19.01.19 19.01.19 -
  2. 11.02.20 11.02.20 - Christian Arras
  3. 04.03.20 04.03.20 - Christian Arras
Rechteinhaber

see on clinicaltrials.gov

Hochgeladen am

19. Januar 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Psoriatic Arthritis NCT02470481

Eligibility Psoriatic Arthritis NCT02470481

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient must be a man or woman aged 18 to 65 years of age, inclusive
Beschreibung

ID.1

Datentyp

boolean

the patient must have an established diagnosis of psoriasis (based upon clinical evidence, and documented medical history [19])
Beschreibung

ID.2

Datentyp

boolean

the patient must be able to read and write in the target language (english, mandarin or korean; or other relevant target languages)
Beschreibung

ID.3

Datentyp

boolean

each patient must sign an informed consent form (icf) indicating that he or she understands the purpose of and procedures required for the study and are willing to participate in the study
Beschreibung

ID.4

Datentyp

boolean

Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
an established diagnosis of psoriatic arthritis
Beschreibung

ID.5

Datentyp

boolean

ever have received systemic treatment with a disease modifying antirheumatic drug (dmard) for arthritis or spondylitis (inflammatory back pain)
Beschreibung

ID.6

Datentyp

boolean

ever have received systemic treatment with a biologic therapy for psoriasis (including infliximab, golimumab, ustekinumab, adalimumab or etanercept)
Beschreibung

ID.7

Datentyp

boolean

a history of employment in or are currently employed in the healthcare industry; or
Beschreibung

ID.8

Datentyp

boolean

participated in the translation and linguistic validation of the earp questionnaire
Beschreibung

ID.9

Datentyp

boolean

Ähnliche Modelle

Eligibility Psoriatic Arthritis NCT02470481

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patient must be a man or woman aged 18 to 65 years of age, inclusive
boolean
ID.2
Item
the patient must have an established diagnosis of psoriasis (based upon clinical evidence, and documented medical history [19])
boolean
ID.3
Item
the patient must be able to read and write in the target language (english, mandarin or korean; or other relevant target languages)
boolean
ID.4
Item
each patient must sign an informed consent form (icf) indicating that he or she understands the purpose of and procedures required for the study and are willing to participate in the study
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
an established diagnosis of psoriatic arthritis
boolean
ID.6
Item
ever have received systemic treatment with a disease modifying antirheumatic drug (dmard) for arthritis or spondylitis (inflammatory back pain)
boolean
ID.7
Item
ever have received systemic treatment with a biologic therapy for psoriasis (including infliximab, golimumab, ustekinumab, adalimumab or etanercept)
boolean
ID.8
Item
a history of employment in or are currently employed in the healthcare industry; or
boolean
ID.9
Item
participated in the translation and linguistic validation of the earp questionnaire
boolean

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video